Delilah Alvarado
Associate EditorDelilah is an associate editor for BioPharma Dive. Before Industry Dive she covered business tech and startup news and has reported on social issues, politics and culture. She has a B.S. from Texas State University and is obsessed with dogs and horror films.
17 articles by Delilah Alvarado
-
New RSV vaccines can be powerful tools, but rollout poses test
Sept. 18, 2023 -
CDC endorses new COVID boosters as focus turns to rollout
Sept. 13, 2023 -
Appeals court rules to limit abortion pill access
Aug. 16, 2023 -
First nonprescription birth control pill approved by FDA
July 13, 2023 -
Supreme Court maintains access to abortion pill, blocking restrictions on its use
April 21, 2023 -
Supreme Court delays decision in court battle over abortion pill
April 19, 2023 -
FDA favors single dose of updated COVID shots in shift to simplify vaccination
April 19, 2023 -
Appeals court rules abortion drug can stay on market — but limits access
April 13, 2023 -
Federal judge invalidates FDA approval of abortion pill
April 10, 2023 -
Biotech fears ‘dangerous’ precedent as judge challenges FDA authority
April 10, 2023 -
FDA approves Narcan for over-the-counter use
March 30, 2023 -
‘I don’t feel safe.’ Abortion bans add new uncertainty to fertility treatment
Oct. 24, 2022 -
CDC backs updated COVID-19 shots from Pfizer, Moderna
Sept. 2, 2022 -
FDA clears updated COVID-19 boosters from Pfizer, Moderna
Aug. 31, 2022 -
Lilly criticizes Indiana abortion law, indicating it may look elsewhere to hire
Aug. 8, 2022 -
CDC backs Novavax's protein-based vaccine for COVID-19
July 21, 2022 -
Pfizer seeks full FDA approval of Paxlovid as questions about its benefits grow
June 30, 2022